Insurances.net
insurances.net » Wholesale Business » Aarkstore Enterprise---celsion Corporation (clsn) - Financial And Strategic Analysis Review
Home Business Small Business Wholesale Business Business agency Global Economy
]

Aarkstore Enterprise---celsion Corporation (clsn) - Financial And Strategic Analysis Review

Aarkstore Enterprise---celsion Corporation (clsn) - Financial And Strategic Analysis Review

Celsion Corporation (Celsion) is a biotechnology company engaged in the development and marketing of drugs to treat cancer and other diseases

. Its flagship product ThermoDox is currently undergoing pivotal Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer (RCW). It is also developing numerous products that employ its heat activated liposomal technology. The company has licensed ThermoDox to Yakult-Honsha for the Japanese market.

Celsion Corporation Key Recent Developments

May 13, 2010: Celsions Phase III ThermoDox(R) HEAT Study Recommended for Continuation by Data Monitoring Committee

May 04, 2010: Celsion Reports Q1 2010 Results

Feb 22, 2010: Celsions Technology Is The Focus Of EUR6.4 Million HIFU-CHEM Program To Study ThermoDox And MRI-Guided HIFU

Feb 17, 2010: Celsion Reports 2009 Results

Jan 08, 2010: Celsion Announces Departure Of Sean Moran As CFO

This comprehensive SWOT analysis of Celsion Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

For more information please contact :

http://www.aarkstore.com/reports/Celsion-Corporation-CLSN-Financial-and-Strategic-Analysis-Review-62784.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise
Aarkstore Enterprise---world Heart Corporation (whrt) - Financial And Strategic Analysis Review Aarkstore Enterprise---vical Incorporated (vicl) - Financial And Strategic Analysis Review Aarkstore Enterprise---osiris Therapeutics, Inc. (osir) - Financial And Strategic Analysis Review Aarkstore Enterprise---victhom Human Bionics Inc. (vhb) - Financial And Strategic Analysis Review Aarkstore Enterprise---shimadzu Corporation (7701) - Financial And Strategic Analysis Review Aarkstore Enterprise---xcounter Ab (xct) - Financial And Strategic Analysis Review Aarkstore Enterprise---ventracor Limited (vcr) - Financial And Strategic Analysis Review Aarkstore Enterprise---aloka Co., Ltd. (7704) - Financial And Strategic Analysis Review Aarkstore Enterprise---inyx, Inc. (iyxi) - Financial And Strategic Analysis Review Aarkstore Enterprise---moog Inc. (mog.a) - Financial And Strategic Analysis Review Aarkstore Enterprise---biotage Ab (biot) - Financial And Strategic Analysis Review Aarkstore Enterprise---unilens Vision Inc. (uvi) - Financial And Strategic Analysis Review Aarkstore Enterprise---zila, Inc. (zila) - Financial And Strategic Analysis Review
Write post print
www.insurances.net guest:  register | login | search IP(3.137.166.124) / Processed in 0.012287 second(s), 6 queries , Gzip enabled debug code: 46 , 2519, 496,
Aarkstore Enterprise---celsion Corporation (clsn) - Financial And Strategic Analysis Review